S16 E01 Overcoming Misconceptions about the Canadian Pharma Market
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Canadian General Manager of argenx’s John Haslam discusses the big impact of rare disease, making key antibodies in the autoimmune space, and pricing strategy reform in Canada.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
adbl_web_anon_alc_button_suppression_t1
No reviews yet